Synthesis of methanesulphonamido-benzimidazole derivatives as gastro-sparing antiinflammatory agents with antioxidant effect

Bioorganic & Medicinal Chemistry Letters - Tập 27 Số 13 - Trang 3007-3013 - 2017
Rupali Sharma1, Alka Bali1, Bhim Bahadur Chaudhari1
1University Institute of Pharmaceutical Sciences, UGC Center of Advanced Study, Panjab University, Chandigarh, 160014, India

Tóm tắt

Từ khóa


Tài liệu tham khảo

Bennet, 2005, The use of nonsteroidal anti-inflammatory drugs (NSAIDs): a science advisory from the American Heart Association, Circulation, 111, 1713, 10.1161/01.CIR.0000160005.90598.41

Rainsford, 2007, Anti-inflammatory drugs in the 21st century, Subcell Biochem, 42, 3, 10.1007/1-4020-5688-5_1

Borne, 2002, Non-steroidal anti-inflammatory drugs, 751

Ricciotti, 2011, Prostaglandins and inflammation, Arterioscler Thromb Vasc Biol, 31, 986, 10.1161/ATVBAHA.110.207449

Blazovics, 2004, Cytokines, prostaglandins, nutritive and non nuitritive factors in inflammatory bowel diseases, Orv Hetil, 145, 2523

Mastuoka, 2000, Prostaglandin D2 as a mediator of allergic asthma, Science, 287, 2013, 10.1126/science.287.5460.2013

Ruan, 2010, Prostacyclin therapy for pulmonary arterial hypertension, Tex Heart Inst J, 37, 391

Green, 2001, Understanding NSAIDS: From aspirin to COX-2, Clin Cornerstone, 3, 50, 10.1016/S1098-3597(01)90069-9

Laine, 2001, Approaches to non-steroidal anti-inflammatory drug use in the high-risk patient, Gastroenterology, 120, 594, 10.1053/gast.2001.21907

Vonkeman, 2010, Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention, Semin Arthritis Rheum, 39, 294, 10.1016/j.semarthrit.2008.08.001

Unsal-Tan, 2012, Molecular modeling, synthesis and screening of some new 4-thiazolidinone derivatives with promising selective COX-2 inhibitory activity, Eur J Med Chem, 57, 59, 10.1016/j.ejmech.2012.08.046

Dogne, 2005, Adverse effects of coxibs, J Med Chem, 48, 2251, 10.1021/jm0402059

Licata, 2010, Clinical course and outcomes of drug-induced liver injury: nimesulide as the first implicated medication, Dig Liver Dis, 42, 743, 10.1016/j.dld.2009.06.009

Bhattacharyya, 2014, Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases, Physiol Rev, 94, 329, 10.1152/physrev.00040.2012

Ghosh, 2015, NSAIDs and cardiovascular diseases: role of reactive oxygen species, Oxid Med Cell Longev, 2015, 536962, 10.1155/2015/536962

Kuş, 2010, Antioxidant and antifungal properties of benzimidazole derivatives, Z Naturforsch, 65c, 537, 10.1515/znc-2010-9-1002

Kourounakis, 2000, Reduction of gastrointestinal toxicity of NSAIDs via molecular modifications leading to antioxidant anti-inflammatory drugs, Toxicology, 144, 205, 10.1016/S0300-483X(99)00208-5

Jayabharathi, 2013, Synthesis of some fluorescent benzimidazole derivatives using cobalt hydroxide (II) as high efficient catalyst - Spectral, physico-chemical studies and ESIPT process, Photochem Photobiol Sci, 12, 1761, 10.1039/c3pp50083g

Jayabharathi, 2013, Synthesis, spectral studies and solvatochromism of some novel benzimidazole derivatives - ESIPT process, Spectrochim Acta Part A Mol Biomol Spectrosc, 105, 223, 10.1016/j.saa.2012.12.037

Bali, 2012, Synthesis, evaluation and docking studies on 3-alkoxy-4-methanesulfonamidoacetophenone derivatives as non ulcerogenic anti-inflammatory agents, Eur J Med Chem, 49, 397, 10.1016/j.ejmech.2012.01.018

Winter, 1962, Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs, Proc Soc Exp Biol, 111, 544, 10.3181/00379727-111-27849

Tributino, 2009, Bioorg Med Chem, 17, 1125, 10.1016/j.bmc.2008.12.045

2008, 1236

Oyaizu, 1986, Studies on products of browning reactions: antioxidative activities of products of browning reaction prepared from glucosamine, Jpn J Nutr, 44, 307, 10.5264/eiyogakuzashi.44.307

Clark, 2000, Computational methods for the prediction of ‘drug-likeness’, Drug Discov Today, 5, 49, 10.1016/S1359-6446(99)01451-8

Lipinski, 2001, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv Drug Deliv Rev, 46, 3, 10.1016/S0169-409X(00)00129-0